MARC Record from Library of Congress

LEADER: 01811cam a2200385 a 4500
001 2012540273
003 DLC
005 20141208132821.0
008 130301s2012 flua b 001 0 eng c
010 $a 2012540273
016 7 $a101577395$2DNLM
016 7 $a015865031$2Uk
020 $a9781439851401 (hbk. : alk. paper)
020 $a1439851409 (hbk. : alk. paper)
035 $a(OCoLC)ocn635488898
040 $aNLM$beng$cNLM$dBTCTA$dYDXCP$dUKMGB$dILU$dE7B$dOCLCQ$dDLC
042 $apcc
050 00 $aRC776.O3$bO27 2012
060 00 $a2012 A-875
060 10 $aWF 600
082 00 $a616.2/4$223
245 00 $aObstructive airway diseases :$brole of lipid mediators /$cedited by Abhijit Ray, Punit Kumar Srivastava.
260 $aBoca Raton, FL :$bCRC,$cc2012.
300 $axiv, 367 p. :$bill. ;$c24 cm.
504 $aIncludes bibliographical references and index.
520 $a"Incidences of inflammatory airway diseases are on the rise across the world. Existing therapeutic options are ineffective, unsafe, and expensive, and severe cases are nonresponsive to conventional therapy. Therefore, it is imperative that research be undertaken to discover new treatment options. Obstructive Airway Diseases: Role of Lipid Mediators discusses clinically successful and potential lipid targets that can make a difference in treating some of the most intractable disease states."--Publisher description.
650 0 $aLungs$xDiseases, Obstructive$xPathogenesis.
650 0 $aLungs$xPathophysiology.
650 0 $aLipids$xMetabolism.
650 12 $aPulmonary Disease, Chronic Obstructive$xdrug therapy.
650 12 $aPulmonary Disease, Chronic Obstructive$xphysiopathology.
650 22 $aInflammation Mediators.
650 22 $aLipids.
700 1 $aRay, Abhijit,$cDr.
700 1 $aSrivastava, Punit Kumar.